Related references
Note: Only part of the references are listed.Detection of hepatic micrometastases in the context of adjuvant chemotherapy and surgery for hepatic metastases
C. C. Schimanski et al.
DEUTSCHE MEDIZINISCHE WOCHENSCHRIFT (2010)
Maintenance and Consolidation Therapy in Patients with Unresectable Stage III/IV Non-Small Cell Lung Cancer
Nicholas Thatcher et al.
ONCOLOGIST (2010)
S3 Guidelines for Colorectal Carcinoma Results of an Evidence-Based Consensus Conference on February 6/7, 2004 and June 8/9, 2007 (for the Topics IV, VI and VII)
W. Schmiegel et al.
ZEITSCHRIFT FUR GASTROENTEROLOGIE (2010)
Adjuvant Chemotherapy After Potentially Curative Resection of Metastases From Colorectal Cancer: A Pooled Analysis of Two Randomized Trials
Emmanuel Mitry et al.
JOURNAL OF CLINICAL ONCOLOGY (2008)
Perioperative chemotherapy with FOLFOX4 and surgery versus surgery alone for resectable liver metastases from colorectal cancer (EORTC Intergroup trial 40983): a randomised controlled trial
Bernard Nordlinger et al.
LANCET (2008)
BLP-25 liposomal vaccine: a promising potential therapy in nonsmall-cell lung cancer
Erin Powell et al.
Expert Review of Respiratory Medicine (2008)
Surgical therapy for colorectal metastases to the liver
Timothy M. Pawlik et al.
JOURNAL OF GASTROINTESTINAL SURGERY (2007)
Adjuvant chemotherapy improves survival after resection of hepatic colorectal metastases: Analysis of data from two continents
Rowan Parks et al.
JOURNAL OF THE AMERICAN COLLEGE OF SURGEONS (2007)
Cancer statistics, 2007
Ahmedin Jemal et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2007)
Multicenter randomized trial of adjuvant fluorouracil and folinic acid compared with surgery alone after resection of colorectal liver metastases: FFCD ACHBTH AURC 9002 trial
Guillaume Portier et al.
JOURNAL OF CLINICAL ONCOLOGY (2006)
OncoSurge: A strategy for improving resectability with curative intent in metastatic colorectal cancer
GJ Poston et al.
JOURNAL OF CLINICAL ONCOLOGY (2005)
Randomized phase IIB trial of BLP25 liposome vaccine in stage IIIB and IV non-small-cell lung cancer
C Butts et al.
JOURNAL OF CLINICAL ONCOLOGY (2005)
Neoadjuvant chemotherapy before liver resection for patients with unresectable liver metastases from colorectal carcinoma
GD Leonard et al.
JOURNAL OF CLINICAL ONCOLOGY (2005)
Human MUC1 carcinoma-associated protein confers resistance to genotoxic anticancer agents
J Ren et al.
CANCER CELL (2004)
Expression of MUC1 recognized by monoclonal antibody MY.1E12 is a useful biomarker for tumor aggressiveness of advanced colon carcinoma
H Suzuki et al.
CLINICAL & EXPERIMENTAL METASTASIS (2004)
Human DF3/MUC1 carcinoma-associated protein functions as an oncogene
YQ Li et al.
ONCOGENE (2003)
Annual report to the nation on the status of cancer, 1975-2000, featuring the uses of surveillance data for cancer prevention and control
HK Weir et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2003)
Neoadjuvant treatment with weekly high-dose 5-fluorouracil as 24-hour infusion, folinic acid and oxaliplatin in patients with primary resectable liver metastases of colorectal cancer
A Wein et al.
ONCOLOGY (2003)
Mutations in APC, Kirsten-ras, and p53 - alternative genetic pathways to colorectal cancer
G Smith et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2002)
Share Paper
